AU8673198A - Il-8 receptor antagonists - Google Patents
Il-8 receptor antagonistsInfo
- Publication number
- AU8673198A AU8673198A AU86731/98A AU8673198A AU8673198A AU 8673198 A AU8673198 A AU 8673198A AU 86731/98 A AU86731/98 A AU 86731/98A AU 8673198 A AU8673198 A AU 8673198A AU 8673198 A AU8673198 A AU 8673198A
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5400197P | 1997-07-29 | 1997-07-29 | |
| US60054001 | 1997-07-29 | ||
| PCT/US1998/015830 WO1999006354A1 (en) | 1997-07-29 | 1998-07-29 | Il-8 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8673198A true AU8673198A (en) | 1999-02-22 |
Family
ID=21988053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU86731/98A Abandoned AU8673198A (en) | 1997-07-29 | 1998-07-29 | Il-8 receptor antagonists |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1000017A4 (en) |
| JP (1) | JP2001512096A (en) |
| AU (1) | AU8673198A (en) |
| CA (1) | CA2294064A1 (en) |
| WO (1) | WO1999006354A1 (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000059490A2 (en) | 1999-04-06 | 2000-10-12 | Genzyme Corporation | Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| UY26206A1 (en) * | 1999-06-16 | 2000-12-29 | Smithkline Beecham Plc | IL-8 RECEPTOR ANTAGONISTS. |
| FR2801585B1 (en) | 1999-11-25 | 2002-02-15 | Fournier Ind & Sante | NEW II-8 RECEPTOR ANTAGONISTS |
| DE10109204A1 (en) * | 2001-02-26 | 2002-09-19 | 4Sc Ag | Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
| WO2002070467A1 (en) | 2001-02-26 | 2002-09-12 | 4Sc Ag | Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| MY143477A (en) | 2002-10-29 | 2011-05-31 | Smithkline Beecham Corp | Il-8 receptor antagonists |
| US7186725B2 (en) | 2003-01-03 | 2007-03-06 | Genzyme Corporation | Anti-inflammatory compositions and methods |
| TW200523253A (en) | 2003-07-22 | 2005-07-16 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| CN1926114B (en) | 2004-03-23 | 2011-08-24 | 艾尼纳制药公司 | Processes for preparing substituted N-aryl-N'-[3-(1H-pyrazol-5-yl) phenyl] ureas and intermediates thereof |
| SA05260357B1 (en) | 2004-11-19 | 2008-09-08 | ارينا فارماسيتو تيكالز ، أنك | 3-phenyle-pyrazole derivatives as modulators of the 5-ht 2a serotonin receptor useful for the treatment of disorders related thereto |
| JP5269763B2 (en) | 2006-04-21 | 2013-08-21 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | IL-8 receptor antagonist |
| CA2650007A1 (en) | 2006-04-21 | 2007-11-01 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| SG171681A1 (en) | 2006-05-18 | 2011-06-29 | Arena Pharm Inc | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor |
| AU2007254244C1 (en) | 2006-05-18 | 2014-07-31 | Arena Pharmaceuticals, Inc. | 3-pyrazolyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| USRE45336E1 (en) | 2006-05-18 | 2015-01-13 | Arena Pharmaceuticals, Inc. | Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| TWI415845B (en) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| JP5393677B2 (en) | 2007-08-15 | 2014-01-22 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Imidazo [1,2-a] pyridine derivatives as modulators of 5-HT2A serotonin receptors for the treatment of disorders associated with 5-HT2A serotonin receptors |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062323A2 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| WO2011075596A1 (en) | 2009-12-18 | 2011-06-23 | Arena Pharmaceuticals, Inc. | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| MX2017016413A (en) | 2015-06-12 | 2018-08-01 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder. |
| CA2992518A1 (en) | 2015-07-15 | 2017-01-19 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11503110A (en) * | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | IL-8 receptor antagonist |
| US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| BR9709938A (en) * | 1996-06-27 | 1999-08-10 | Smithkline Beecham Corp | Il-8 receptor antagonists |
-
1998
- 1998-07-29 AU AU86731/98A patent/AU8673198A/en not_active Abandoned
- 1998-07-29 CA CA002294064A patent/CA2294064A1/en not_active Abandoned
- 1998-07-29 EP EP98938138A patent/EP1000017A4/en not_active Withdrawn
- 1998-07-29 JP JP2000505116A patent/JP2001512096A/en not_active Withdrawn
- 1998-07-29 WO PCT/US1998/015830 patent/WO1999006354A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001512096A (en) | 2001-08-21 |
| EP1000017A1 (en) | 2000-05-17 |
| CA2294064A1 (en) | 1999-02-11 |
| WO1999006354A1 (en) | 1999-02-11 |
| EP1000017A4 (en) | 2000-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA988100B (en) | IL-8 receptor antagonists | |
| IL131004A0 (en) | Il-8 receptor antagonists | |
| IL127666A0 (en) | IL-8 receptor antagonists | |
| HUP9903922A3 (en) | Il-8 receptor antagonists | |
| EP0932405A4 (en) | Il-8 receptor antagonists | |
| IL125717A0 (en) | Il-8 receptor antagonists | |
| AU8673198A (en) | Il-8 receptor antagonists | |
| IL128501A0 (en) | IL-8 receptor antagonists | |
| EP1019035A4 (en) | Il-8 receptor antagonists | |
| EP0907362A4 (en) | Il-8 receptor antagonists | |
| EP0920417A4 (en) | Il-8 receptor antagonists | |
| IL131005A0 (en) | Il-8 receptor antagonists | |
| AU6435098A (en) | Il-8 receptor antagonists | |
| HK1028730A1 (en) | Il-8 receptor antagonists | |
| AU1296899A (en) | Phenyl-alkyl-imidazoles as h3 receptor antagonists | |
| EP0923373A4 (en) | Il-8 receptor antagonists | |
| EP0957907A4 (en) | Il-8 receptor antagonists | |
| EP0939634A4 (en) | Il-8 receptor antagonists | |
| AU2234199A (en) | Il-8 receptor antagonists | |
| EP0934066A4 (en) | Il-8 receptor antagonists | |
| EP0920253A4 (en) | Il-8 receptor antagonists | |
| EP0948330A4 (en) | Il-8 receptor antagonists | |
| AU6051200A (en) | Il-8 receptor antagonists | |
| AU6826498A (en) | Endotholin receptor antagonists | |
| AU6826698A (en) | Endothelin receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |